Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2013.180 | Effects of Integrated Attention training on cognition and everyday function for healthy older Chinese adults with subjective cognitive complaints but no clinical dementia | Dr Ma Suk Ling |
| 2013.179 | Effects of Antenatal Vitamin D Supplementationation on Postpartum Depression: A Randomized, Controlled, Double-blinded Clinical Trial among Chinese Women in Hong Kong | Professor Wong Carmen |
| 2013.175 | Multi-centre, randomised, double-blind and placebo-controlled clinical trial of vitamin D treatment for childhood eczema | Professor Hon Kam-Lun Ellis |
| 2013.168 | Impact of a Professional Development Program on the Student Learning Outcome and Teacher Self-Efficacy toward Teaching Games for Understanding | Professor HA Sau-ching Amy |
| 2013.167 | A Multicenter, Open-Label Phase 2 Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung | Prof. MOK Tony Shu Kam |
| 2013.166 | Efficacy and safety of agomelatine (25 mg/day with blinded potential adjustment to 50 mg/day) for 12 weeks in non-depressed out-patients with Generalized Anxiety Disorder. A 12-week randomised, double-blind, versus venlafaxine (75 mg/day with blinded potential adjustment up to 225 mg/day), 2-arm parallel groups, international multicenter study. | Prof. WING Yun Kwok |
| 2013.160 | Cultivation of self-compassion and mindfulness through mobile applications for the promotion of mental well-being: a randomized controlled trial | Prof. MAK Winnie Wing Sze |
| 2013.159 | A phase II trial of neoadjuvant imatinib for large gastric GIST in Asia | Professor Ng Enders Kwok Wai |
| 2013.156 | A multi-centre 3-year follow-up study to assess the durability of sustained virologic response in Alisporivir-treated chronic Hepatitis C patients | Prof. Chan Henry Lik-Yuen |
| 2013.154 | A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF ALEGLITAZAR MONOTHERAPY COMPARED WITH PLACEBO IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2D) WHO ARE DRUG-NA_VE TO ANTIHYPERGLYCEMIC THERAPY | Dr. Tsang Chiu Chi |
| 2013.153 | A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF ALEGLITAZAR MONOTHERAPY COMPARED WITH PLACEBO IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2D) WHO ARE DRUG-NA_VE TO ANTIHYPERGLYCEMIC THERAPY | Prof. Kong Pik Shan |
| 2013.152 | A randomized controlled trial of a tailored intervention targeted smoking type 2 diabetic patients to promote smoking cessation and improve glycamic control | Dr. Ozaki Risa |
| 2013.151 | A randomized control trial for a structured exercise promotion program for stage I to Stage III breast cancer patients during adjuvant chemotherapy and radiotherapy to evaluate its efficacy by physical activity level, quality of life, fatigue level and shoulder range of motion. | Chan Sau Man Mandy |
| 2013.141 | Comparison in treatment effects on tennis elbow between using acupuncture and extracorporeal shockwave, randomized controlled trial study design, single-blinded, measured by pain intensity, maximal grip strength and functional impairment | Miss Ng Yin Ling |
| 2013.130 | The effectiveness of extracorporeal shockwave therapy De Quervain's tenosynovitis, non-randomized controlled study,measured by pain intensity, maximal grip strength and Ulnar deviation | Ms Ho Shuk Ling |
| 2013.123 | A cluster randomized controlled trial of an integrated physical cognitive exercise intervention on cognitive and everyday function in older adults living with Mild Alzheimer's disease | Professor Lam Linda Chiu-wa |
| 2013.119 | Effect of natural S-equol on blood pressure and vascular function - a six-month randomized, double-blind and placebo-controlled trial among equol non-producers of postmenopausal women with prehypertension or untreated stage 1 hypertension | Dr. Liu Zhaomin |
| 2013.117 | An Open Label, Phase 2a, Single-Arm Study of the Antifibrotic Activity of FG-3019 in Subjects with Advanced Liver Fibrosis due to Chronic Hepatitis C Infection (HCV) | Dr. Hui Aric Josun |
| 2013.115 | An Open Label, Phase 2a, Single-Arm Study of the Antifibrotic Activity of FG-3019 in Subjects with Advanced Liver Fibrosis due to Chronic Hepatitis C Infection (HCV) | Prof Chan Lik Yuen Henry |
| 2013.105 | A randomized controlled trial on the efficacy of tenofovir disoproxil fumarate (TDF)-switch therapy in chronic hepatitis B patients with incomplete response to entecavir | Dr. WONG Grace Lai Hung |
| 2013.098 | A Multicenter Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145 | Dr Ozaki Risa |
| 2013.097 | Application of Low-Magnitude High-Frequency Vibration to Retard the Progress of Sarcopenia | Professor Cheung Wing Hoi |
| 2013.094 | A randomized controlled trial to investigate the independent and joint effects of diet and exercise on endogenous estrogen concentrations among overweight/obese postmenopausal Chinese women in Hong Kong | Prof. Su Xuefen |
| 2013.089 | ARCHER 1050: A RANDOMIZED, OPEN-LABEL, PHASE 3, EFFICACY AND SAFETY STUDY OF DACOMITINIB (PF-00299804) VERSUS GEFITINIB FOR THE FIRST LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN SUBJECTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) ACTIVATING MUTATION(S) | Prof. MOK Tony Shu Kam |
| 2013.088 | A Phase 1/2, Dose-escalation, Open-label, Non-comparative Study of Nivolumab or Nivolumab in Combination with Ipilimumab in Advanced Hepatocellular Carcinoma Subjects with or without Chronic Viral Hepatitis; and a Randomized, Open-label Study of Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Subjects who are Naive to Systemic Therapy | Prof. YEO Winnie |
| 2013.081 | A Randomized, Single-blinded, Controlled Trial to Investigate the Efficacy of Low-Magnitude High-Frequency Vibration Treatment on Early Stage Osteoarthritic Knee (VTOAK) | Professor Leung Kwok Sui |
| 2013.073 | The Impact of Breakfast Glycemic Index on Appetite Control in Primary School Teachers in Hong Kong: A Randomized Cross-over Design | Prof. Wong Heung-Sang Stephen |
| 2013.071 | A Multicenter, Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 145 on LDL-C in Subjects With Severe Familial Hypercholesterolemia | Dr. LUK Andrea On Yan |
| 2013.070 | A Multicenter, Controlled, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145 | Dr. LUK Andrea On Yan |
| 2013.069 | A 2-Part, Phase 2/3 Study to Assess the Safety, Tolerability and Efficacy of AMG 145 in Subjects With Homozygous Familial Hypercholesterolemia Part A - Open-label, Single-arm, Multicenter Pilot Study to Evaluate Safety, Tolerability, and Efficacy of AMG 145 in Subjects With Homozygous Familial Hypercholesterolemia Part B - Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 in Subjects With Homozygous Familial Hypercholesterolemia | Professor Tomlinson Brian |
| 2013.066 | Master Study of the BIOTRONIK DF4 System | Prof. YU Cheuk Man |
| 2013.065 | Baduanjin (a Chinese Traditional Exercise) for Elder Adults with Mild Cognitive Impairment (MCI): a Randomized Controlled Trial | Prof. LEUNG Albert Wing Nang |
| 2013.064 | Computer assisted intervention using touch-screen video game technology on cognitive and behavioral symptoms for community-living older adults with mild to moderate dementia | Dr. YU Ruby |
| 2013.054 | The Immediate effect of Electroacupuncture on treadmill exercise running time in Young and Healthy Sedentary Adults | Miss Chan Yuk Lui |
| 2013.052 | Pharmacogenomics of anti-hypertensive treatment in Chinese, from unpredictable response to personalized medicine | Prof Tomlinson Brian |
| 2013.047 | An Open-Label, Multicenter Evaluation of the Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor VIII Fusion Protein (rFVIIIFc) in the Prevention and Treatment of Bleeding Episodes in Previously Treated Subjects With Hemophilia A | Dr. LI Chi Kong |
| 2013.001 | A Phase II, open label, single arm, multicenter study of INC280 administered orally in adult patients with advanced hepatocellular carcinoma | Prof. CHAN Stephen Lam |
| 2012.581 | A Multicenter, International, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis | Prof. LEUNG Ping Chung |
| 2012.576 | Can we prevent insomnia? - A randomized controlled trial of brief cognitive-behavioral insomnia prevention program for high-risk adolescents | Prof. WING Yun Kwok |
| 2012.574 | Effect of Membrane Permeability on Inflammatory Indices and Arterial Stiffness in Patients Receiving Home Haemodialysis: A Randomized Study | Dr. LAU Wai Yan |
| 2012.569 | Pneumodilation Or Endoscopic Myotomy in Achalasia (POEMA) Trial | Prof. CHIU Philip Wai Yan |
| 2012.568 | An Investigation of the Effect of Electrical Stimulation on Lower Esophageal Sphincter (LES) Pressure and Esophageal Acid Exposure in Patients with Symptomatic Gastroesophageal Reflux Disease (GERD) | Prof Wu Che Yuen Justin |
| 2012.566 | Does a patient navigation system improve quality of life and health outcomes of cancer patients in Hong Kong: A feasibility study | Dr. KWONG Elizabeth Ming Sum |
| 2012.563 | Effect of preoperative patient education on postoperative care in an intensive care unit for preventing delirium after cardiac surgery: a randomized controlled trial | Prof. LEE Anna |
| 2012.561 | Novel Treatment of Intermittent Claudication in Patients with Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule | Prof. YAN Bryan Ping Yen |
| 2012.559 | A randomized, double-blind, parallel, placebo-controlled study assessing the efficacy and safety of sarilumab added to non-biologic DMARD therapy in patients with rheumatoid arthritis who are inadequate responders to or intolerant of TNF-α antagonists | Prof. TAM Lai Shan |
| 2012.558 | An adaptive Phase II study to evaluate the efficacy, pharmacodynamics, safety and tolerability of GSK2586184 in patients with mild to moderate systemic lupus erythematosus | Professor Tam Lai Shan |
| 2012.557 | A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab | Prof. TAM Lai Shan |
| 2012.554 | A study to compare the “Ergomotor” Intervention Program to conventional physiotherapy treatment in managing work-related neck-shoulder disorders: A randomized controlled trial | Dr SZETO Pui Yuk Grace |
| 2012.552 | Regression Of Cerebral Arteriosclerotic white matter lesion progression using Statins (ROCAS 2) study | Prof Mok Vincent Chung Tong |
Page 251 of 287.